Advertisement
New Zealand markets closed
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NZD/USD

    0.5945
    -0.0005 (-0.08%)
     
  • NZD/EUR

    0.5553
    +0.0013 (+0.23%)
     
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • OIL

    83.63
    +0.06 (+0.07%)
     
  • GOLD

    2,349.80
    +7.30 (+0.31%)
     
  • NASDAQ

    17,750.46
    +319.96 (+1.84%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,281.94
    +196.14 (+0.51%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • NZD/JPY

    93.7550
    +1.2590 (+1.36%)
     

Want Rising Passive Income? Consider These 2 Stocks for Your Portfolio

Want Rising Passive Income? Consider These 2 Stocks for Your Portfolio

Serving more than 100 million customers through its pharmacy benefit manager CVS Caremark and managed care company Aetna, CVS Health (NYSE: CVS) is a company critical to the healthcare sector. It's a safe bet that as long as there is still a need for prescriptions and health insurance, the company will likely do well for its shareholders. This is why analysts believe that CVS Health's non-GAAP (generally accepted accounting principles) adjusted diluted earnings per share (EPS) will compound by 5.9% annually over the next five years.